INNT
TOTAL INVALIDATION PROCESSED BY THE IB
19/04/2025
Voltar para busca
Dado oficial do USPTO
BICYCLE DRUG CONJUGATE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BICYCLE DRUG CONJUGATE
ST13
US500000079189674Classe
5, 42
Pedido
79189674
Registro
5314176
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
14/05/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
06/04/2016
Data de registro
24/10/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/05/2024
Última transação
14/05/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
BIBB, SCOTT
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Bicycletx Limited
Bicycle Therapeutics Limited
Representantes
Jacqueline P. Scheib Robinson & Cole LLP
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical productspharmaceutical preparations for use in oncology for both solid and liquid tumorsmetabolic diseaseurology and renal diseasecardiovascularhematologyrespiratorychronic and acute inflammatory disease and auto-immune disordersgastrointestinal diseasebacterial and viral infectious diseaseneurological and psychiatric disorders; pharmaceutical preparations for use as diagnostics and clinical imaging agents
Classe 42
Scientific and technological servicesnamely scientific research in the field of human and veterinary disease; diagnosis of diseasenamely scientific study and research in the field of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumorsmetabolic diseaseurology and renal diseasecardiovascularhematologyrespiratorychronic and acute inflammatory disease and auto-immune disordersgastrointestinal diseasebacterial and viral infectious diseaseneurological and psychiatric disordersdiagnostics and clinical imaging agents; industrial analysis and research services in the field of oncology for both solid and liquid tumorsmetabolic diseaseurology and renal diseasecardiovascularhematologyrespiratorychronic and acute inflammatory disease and auto-immune disordersgastrointestinal diseasebacterial and viral infectious diseaseneurological and psychiatric disordersdiagnostic preparations and clinical imaging agents; providing informationconsultancy and advisory services relating to the designplanning and implementation of scientific and clinical research for othersnamely designplanning and implementation project management of scientific research and clinical trials
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
27/03/2025
INPC
INVALIDATION PROCESSED
27/03/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
11/01/2025
C71T
CANCELLED SECTION 71
10/05/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/12/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
24/10/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
24/09/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
17/09/2021
CHLD
CHANGE OF OWNER RECEIVED FROM IB
21/03/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
16/03/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
30/01/2018
FIMP
FINAL DISPOSITION PROCESSED
30/01/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/01/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
24/10/2017
GPNX
NOTIFICATION PROCESSED BY IB
18/08/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/08/2017
PUBO
PUBLISHED FOR OPPOSITION
08/08/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/08/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/08/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/07/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/06/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/06/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/06/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
28/06/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/06/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/06/2017
CNFR
FINAL REFUSAL MAILED
17/04/2017
CNFR
FINAL REFUSAL WRITTEN
14/04/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/02/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/02/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/02/2017
RFNT
REFUSAL PROCESSED BY IB
09/09/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
25/08/2016
RFRR
REFUSAL PROCESSED BY MPU
25/08/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
23/08/2016
CNRT
NON-FINAL ACTION WRITTEN
22/08/2016
MAFR
APPLICATION FILING RECEIPT MAILED
09/08/2016
DOCK
ASSIGNED TO EXAMINER
05/08/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/08/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/08/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BICYCLE DRUG CONJUGATE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.